Since taking on this new position in early 2016, Dr. Majnemer has actively engaged in consultations with a wide variety of stakeholders, as she undertakes the development of a strategic plan for education across the Faculty of Medicine.
Targeting the biological clock could slow the growth of cancer cells
A new study conducted by Nicolas Cermakian, a professor at McGill’s Department of Psychiatry, and published in BMC Biology, shows for the first time that directly targeting the biological clock in a cancerous tumour has an impact on its development.
Dr. Kenneth Melville, a true pioneer, was not only McGill’s first black medical student and first black Chair of the Department of Pharmacology and Therapeutics, but also a leader in his field and an advocate for civil rights.
Neuro scientist receives $1.5M grant for Parkinson’s/ALS research
The project led by Dr. Edward Fon at The Neuro involves the development of a novel drug discovery platform in what will be a new era of therapeutics and personalized medicine for Parkinson’s disease and ALS.
In a paper published recently in the journal Nature, McGill researchers argue that standards for first-time trials of drugs in humans should be strengthened to provide meaningful evidence for potential efficacy.
As Montreal celebrates its 375th anniversary in 2017, read how McGill’s Faculty of Medicine has contributed historically to the city, benefiting members of the community, beginning with the origins of the Faculty itself.